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Abstract Blood is arguably the most important bodily fluid and its analysis provides crucial
health status information. A first routine measure to narrow down diagnosis in clinical practice is
the differential blood count, determining the frequency of all major blood cells. What is lacking to
advance initial blood diagnostics is an unbiased and quick functional assessment of blood that can
narrow down the diagnosis and generate specific hypotheses. To address this need, we introduce
the continuous, cell-by-cell morpho-rheological (MORE) analysis of diluted whole blood, without
labeling, enrichment or separation, at rates of 1000 cells/sec. In a drop of blood we can identify all
major blood cells and characterize their pathological changes in several disease conditions in vitro
and in patient samples. This approach takes previous results of mechanical studies on specifically
isolated blood cells to the level of application directly in blood and adds a functional dimension to
conventional blood analysis.
DOI: https://doi.org/10.7554/eLife.29213.001
Introduction
Blood is responsible for the distribution of oxygen and nutrients, and centrally involved in the
immune response. Consequently, its analysis yields crucial information about the health status of
patients. The complete blood count, the analysis of presence and frequency of all major blood cells,
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constitutes a basic, routine measure in clinical practice. It is often accompanied by analysis of blood
biochemistry and molecular markers reflecting the current focus on molecular considerations in biol-
ogy and biomedicine.
An orthogonal approach could be seen in the study of the overall rheological properties of blood.
It is evident that the flow of blood throughout the body will be determined by its physical properties
in the vasculature, and their alterations could cause or reflect pathological conditions (Licht-
man, 1973; Baskurt and Meiselman, 2003; Popel and Johnson, 2005). In this context, blood is a
poly-disperse suspension of colloids with different deformability and the flow properties of such
non-Newtonian fluids have been the center of study in hydrodynamics and colloidal physics (Lan and
Khismatullin, 2012). Probably due to the dominant importance of erythrocytes, at the expense of
sensitivity to leukocyte properties, whole blood rheology has not resulted in wide-spread diagnostic
application.
Focusing on the physical properties of individual blood cells has suggested a third possibility to
glean maximum diagnostic information from blood. Various cell mechanics measurement techniques,
such as atomic force microscopy (Worthen et al., 1989; Rosenbluth et al., 2006; Lam et al., 2008),
micropipette aspiration (Lichtman, 1973; Lichtman, 1970; Dombret et al., 1995; Ravetto et al.,
2014) or optical traps (Lautenschla¨ger et al., 2009; Ekpenyong et al., 2012; Paul et al., 2013),
have been used to show that leukocyte activation, leukemia, and malaria infection, amongst many
other physiological and pathological changes, lead to readily quantifiable mechanical alterations in
the major blood cells (Worthen et al., 1989; Lautenschla¨ger et al., 2009; Schmid-Scho¨nbein et al.,
1973; Suresh et al., 2005; Rosenbluth et al., 2008; Bow et al., 2011; Gossett et al., 2012). These
proof-of-concept studies have so far been done on few tens of specifically isolated cells. This line of
research has not progressed towards clinical application for lack of an appropriate measurement
technique that can assess single-cell properties of sufficient number directly in blood.
eLife digest When you are sick and go to the doctor, it is often not obvious what exactly is
wrong — what is causing fever, nausea, shortness of breath or other symptoms. It is important to
find this out quickly so that the right action can be taken. One of the first steps is to obtain a blood
sample and to count how many of the different blood cells are present in it. This is called a
complete blood count, and the information it provides has turned out to be surprisingly useful. A
large number of certain white blood cells, for example, can show that the body is fighting an
infection. But there might be several reasons why the number of white blood cells has increased, so
this information alone is often not enough for a specific diagnosis.
There are many hundreds of possible tests that can supplement the results of a complete blood
count. These might identify bacteria or measure the concentrations of certain molecules in the
blood, for example. But which test will give the important clue that reveals the source of the illness?
This can be difficult to predict. Although each test helps to narrow down the final diagnosis they
become increasingly expensive and time-consuming to perform, and rapid action is often important
when treating a disease.
Can we get more decisive information from the initial blood test by measuring other properties
of the blood cells? Toepfner et al. now show that this is possible using a technique called real-time
deformability cytometry. This method forces the blood cells in a small drop of blood to flow
extremely rapidly through a narrow microfluidic channel while they are imaged by a fast camera. A
computer algorithm can then analyze the size and stiffness of the blood cells in real-time. Toepfner
et al. show that this approach can detect characteristic changes that affect blood cells as a result of
malaria, spherocytosis, bacterial and viral infections, and leukemia. Furthermore, many thousands of
blood cells can be measured in a few minutes — fast enough to be suitable as a diagnostic test.
These proof-of-concept findings can now be used to develop actual diagnostic tests for a wide
range of blood-related diseases. The approach could also be used to test which of several drugs is
working to treat a certain medical condition, and to monitor whether the treatment is progressing as
planned.
DOI: https://doi.org/10.7554/eLife.29213.002
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This report aims to close this gap by presenting a novel approach for high-throughput single-cell
morpho-rheological (MORE) characterization of all major blood cells in continuous flow. Mimicking
capillary flow, we analyze human blood without any labeling or separation at rates of 1000 cells/sec.
We show that we can sensitively detect morphological and rheological changes of erythrocytes in
spherocytosis and malaria infection, of leukocytes in viral and bacterial infection, and of malignant
transformed cells in myeloid and lymphatic leukemias. Readily available quantitative morphological
parameters such as cell shape, size, aggregation, and brightness, as well as rheological information
of each blood cell type with excellent statistics might not only inform further investigation of blood
as a complex fluid. It also connects many previous reports of mechanical changes of specifically iso-
lated cells to a measurement now done directly in blood. As such, it adds a new functional dimen-
sion to conventional blood analysis — a MORE complete blood count — and, thus, opens the door
to a new era of exploration in investigating and diagnosing hematological and systemic disorders.
Results
Establishment of morpho-rheological analysis
In order to establish the normal MORE phenotype of cells found in blood, we obtained venous, cit-
rate-anticoagulated blood of healthy donors, of which 50 ml was diluted in 950 ml of measurement
buffer with a controlled elevated viscosity, but without any additional labeling, sorting, or enrich-
ment. The cell suspension was then pumped through a micro-channel not unlike micro-capillaries in
the blood vasculature (Figure 1A). Brightfield images of the cells, deformed by hydrodynamic shear
stresses in the channel (Mietke et al., 2015), were obtained continuously by RT-DC (Otto et al.,
2015) (see Materials and methods; Video 1). These images revealed distinct differences in overall
morphology, brightness, and amount of deformation between all major cell types found in blood
(Figure 1B). RT-DC further enabled the continuous, real-time quantification of the cross-sectional
area and of the deformed shape (see detailed description in Materials and methods and Figure 1—
figure supplement 1) of an, in principle, unlimited number of cells at measurement rates of 100–
1000 cells/sec (Figure 1C). For each cell detected and analyzed, an image was saved and the aver-
age pixel brightness within the cell determined (Figure 1D, Figure 1—figure supplement 1). This
single-cell MORE analysis of blood revealed distinct and well-separated cell populations in the space
spanned by the three parameters (Video 2). Notably, size and brightness alone — parameters not
unlike those accessible by light scattering analysis in standard flow cytometers — were sufficient for
the identification of the cell types (Figure 1D), so that deformation, as an additional and indepen-
dent parameter, was available for assessing their functional changes. The identity of the individual
cell populations by size and brightness was established by magnetic cell sorting, controlled by fluo-
rescence immunophenotyping, and subsequent MORE analysis (Figure 1—figure supplement 2). A
key feature is the very clear separation of the abundant erythrocytes (red blood cells; RBCs) from
other cells as a result of their much greater deformation and lower brightness. This feature gives
access to leukocyte properties directly in diluted whole blood, without the potentially detrimental
effects of hemolysis (see Figure 1—figure supplement 3) or other separation steps, which are
required for analysis with cell mechanics techniques with lower specificity and throughput, or non-
continuous measurement. This aspect contributes to the well-established field of hemorheology the
possibility to interrogate mechanical properties of all individual blood cells and to specifically investi-
gate their contribution to the overall blood rheological properties.
In extensive tests of the variability of this approach, MORE phenotyping yielded identical results
in repeated measurements of blood from the same donor, with sodium citrate added as an anti-
coagulant and for different storage times (Figure 1—figure supplement 4), between different
donors of both sexes (Figure 1—figure supplement 5), and blood samples taken at different times
during the day (Figure 1—figure supplement 6). This robustness served to establish a norm for the
different cell types (Figure 1E). MORE analysis provided the identity and frequency of all major
white blood cells as with a conventional differential blood count (Figure 1F; Supplementary file 1)
— obtained from a single drop of blood, with minimal preparation, and within 15 min. Going beyond
this current gold-standard of routine blood cell analysis, and importantly also beyond all other sin-
gle-blood-cell mechanical analysis studies to date, MORE phenotyping allowed the sensitive charac-
terization of pathophysiological changes of individual cells directly in merely diluted whole blood. In
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the following, we exemplarily demonstrate, in turn for each of the blood cell types, the new possibili-
ties of gaining MORE information from an initial blood test as a time-critical step in generating spe-
cific hypotheses and steering further investigation enabled by this approach.
Figure 1. Single-cell, morpho-rheological phenotyping of blood. (A) Analysis of whole, diluted blood. Hydrodynamic shear forces (red arrows) induce
deformation of cells passing through a microfluidic channel (20  20 mm2) at speeds of more than 30 cm/s (blue arrows). (B) Representative images of
blood cell types acquired. Scale bar is 10 mm. Images are analyzed for cell size as well as (C) cell deformation and (D) average cell brightness. Each dot
represents one of N measurement events. (E) Normal range of deformation and size of cell populations from healthy donors. Each diamond represents
the median of one donor; transparent ellipses indicate 95% confidence areas. (F) Comparison of MORE cell counts with conventional blood count.
DOI: https://doi.org/10.7554/eLife.29213.003
The following source data and figure supplements are available for figure 1:
Source data 1. Source data for Figure 1.
DOI: https://doi.org/10.7554/eLife.29213.010
Figure supplement 1. Definition of RT-DC parameters and illustration of gates.
DOI: https://doi.org/10.7554/eLife.29213.004
Figure supplement 2. Brightness and cell size of purified leukocyte subpopulations in MORE analysis.
DOI: https://doi.org/10.7554/eLife.29213.005
Figure supplement 3. Effect of red blood cell lysis on morpho-rheological properties of leukocytes.
DOI: https://doi.org/10.7554/eLife.29213.006
Figure supplement 4. Stability of results with anti-coagulant and storage time.
DOI: https://doi.org/10.7554/eLife.29213.007
Figure supplement 5. Inter-donor variation of deformation and cell size.
DOI: https://doi.org/10.7554/eLife.29213.008
Figure supplement 6. Intra-day variation of deformation and cell size.
DOI: https://doi.org/10.7554/eLife.29213.009
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Detection of morpho-rheological
changes in erythrocytes
Spherocytosis is a prototypical hereditary disease
in humans in which genetic changes (here ankyrin
and spectrin mutations) cause abnormal shape
and mechanical properties of erythrocytes. Cur-
rent diagnosis is based on the detection of
abnormal cell shapes in a blood smear, followed
up by assessment of the osmotic fragility quanti-
fied by Acidified Glycerol Lysis Time (AGLT) or by
osmotic gradient ektacytometry. These manual
assays take time and do not lend themselves to
quick, initial screening. MORE analysis of the
blood of patients with spherocytosis directly
revealed significantly less deformed and smaller
erythrocytes than normal (Figure 2A–C) as the
functional correlate of the cytoskeletal mutation.
The differences are so clear (Figure 2—figure
supplement 1) that this analysis can serve as a
fast primary and cheap screening test for sphero-
cytosis. Detection of such RBC changes would then warrant confirmation by more specific analysis
using flow-cytometric detection of Eosin-5-Maleimide staining (EMA test) or the direct detection of
the mutation by PCR, which require specific preparation, are more expensive, and thus benefit from
a strong and clear initial hypothesis.
A change in RBC deformability has also been implicated in malaria pathogenesis, since single cells
infected by parasites have been reported to be stiffer (Bow et al., 2011). This insight has not pro-
gressed towards clinical application and the gold standard in malaria diagnosis is still a manual thick
blood smear analysis. To evaluate whether MORE analysis could provide a sensitive, automated
alternative, we analyzed populations of RBCs exposed in vitro to Plasmodium falciparum (P.f.) with a
parasitemia (percentage of actually infected cells) of 7–8% at time points over the 2 day parasite life
cycle. We found a clear, significant, and increasing reduction in the deformation of the entire
exposed RBC population detectable after 4 hr
(Figure 2D–F; Figure 2—figure supplement 2).
Inspection of the individual cell images revealed
the appearance of characteristic features likely
associated with the maturation of parasites
inside a subset of RBCs (Figure 2D,E insets; Fig-
ure 2—figure supplement 2). These features
permitted the direct identification of positively
infected cells, whose relative frequency peaked
at 36 hr (Figure 2—figure supplement 2). The
separate assessment of overtly infected cells
showed an even greater
reduction in deformation than observed in the
entire exposed population (Figure 2F; Fig-
ure 2—figure supplement 2), which — extrapo-
lating our in vitro results to the situation in vivo
— relates to the possibility of clearance of stiff,
infected cells from the circulation by the spleen
(Cranston et al., 1984; Shelby et al., 2003).
However, this small fraction of stiffer cells alone
cannot account for the reduced deformation of
the whole population, so that a bystander stiff-
ening of exposed but non-infected cells seems
involved (Paul et al., 2013).
Video 1. RT-DC in action. Video of the microfluidic
channel system during RT-DC measurement of diluted
whole blood. The cell suspension flows from left to
right through the channel. Cells enter on the left and
are focused by sheath flow from the top and bottom of
the frame towards the narrow RT-DC measurement
channel of 300 mm length and 20 mm width and height
in the right half of the image. RT-DC measurements are
carried out on the cells that travel through the last third
of the length of the measurement channel.
DOI: https://doi.org/10.7554/eLife.29213.011
Video 2. 3D visualization of the separation of leukocyte
populations. Rotating angle view in the space of
deformation, cell size and cell brightness. Cell
identification in order of appearance by coloring:
lymphocytes (blue), neutrophil granulocytes (black),
eosinophil granulocytes (cyan), monocytes (orange),
basophil granulocytes (green).
DOI: https://doi.org/10.7554/eLife.29213.012
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Reduced membrane-cytoskeleton interactions have previously been correlated with elliptocytic
RBCs and resistance to P.f. infection (Chishti et al., 1996). The characteristic biconcave morphology
of RBCs can be chemically altered by the use of 2-bromo-palmitate (2 BP), an efficient inhibitor of
palmitoyl acyltransferases (Biernatowska et al., 2013). Here, 2 BP-treated RBC samples showed
changes in deformation (Figure 2G) with a concurrent reduction in P.f. infectivity (Figure 2H), com-
pared to buffer control or RBCs treated with palmitic acid (PA). PA is an analogue of 2 BP that does
not inhibit palmitoylation (Biernatowska et al., 2013). Since both, 2 BP and PA readily accumulate
in the membranes, but only 2 BP causes a reduction in infectivity of P.f., we suggest that palmitoyla-
tion of RBC proteins is important for RBC morphology and infectivity of P.f. While a previous report
had found no change in infectability of RBCs treated with 2 BP (Jones et al., 2012), the difference
could stem from the different RBC receptors involved in invasion by the different parasite clones
(3D7 vs. HB3), which in turn are differentially affected by palmitoylation. Thus, MORE analysis has
the potential not only to simplify, automate, and speed up malaria diagnosis, but also to provide
additional quantitative information aiding research on the pathogenesis of the disease (Koch et al.,
2017).
Figure 2. Detection of RBC pathologies — spherocytosis and malaria. Exemplary density plots of RBC size vs. deformation in samples from (A) healthy
donor and (B) patient with spherocytosis. (C) Relative median RBC deformation and size in patients with spherocytosis (orange, n = 4 patients)
compared to controls (black, n = 21 donors as in Figure 1E with 68% and 95% confidence ellipses). Density plots of size vs. deformation of (D) control
RBCs and (E) RBCs exposed to P.f. (blue), both after 12 hr incubation. Insets show cells with and without image feature (white inclusion), positively
indicating actual parasite infection. Infected RBCs are indicated by red dots. Scale bars, 10 mm. (F) Evolution of RBC deformation over 46 hr time course
of control (black), P.f. exposed (blue) and P.f. infected RBCs (red); open squares and diamonds, mean ±SD, n = 2; filled squares, individual medians,
**p<0.01, ***p<0.001. (G) Reduced deformation of 2BP-treated RBCs compared to PA- and non-treated controls (mean ±SD of population medians,
n = 4 donors, *p<0.05). (H) Reduced parasitemia in 2BP- compared to PA- and non-treated controls at 2 and 4 days post infection. Error bars: SD
binomial, *p<0.0125.
DOI: https://doi.org/10.7554/eLife.29213.013
The following source data and figure supplements are available for figure 2:
Source data 1. Source data for Figure 2.
DOI: https://doi.org/10.7554/eLife.29213.016
Figure supplement 1. Comparison of erythrocytes in spherocytosis with the healthy control.
DOI: https://doi.org/10.7554/eLife.29213.014
Figure supplement 2. In vitro infection of erythrocytes with Plasmodium falciparum.
DOI: https://doi.org/10.7554/eLife.29213.015
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Detection of morpho-rheological changes in leukocytes
While RBC mechanics has already been used for clinical diagnostics using rheoscopes and ektacy-
tometers for over 40 years (Schmid-Scho¨nbein et al., 1973; Cranston et al., 1984; Reid et al.,
1976), leukocyte mechanics has not been utilized for diagnostic purposes. This is likely due to their
increased stiffness compared to RBCs and a lack of convenient techniques capable of sufficiently
deforming them in suspension — their physiological state. Until recently, techniques with sufficient
throughput, obviating the need for specifically isolating the relevant cells of interest, which always
bears the potential of inadvertent cell change (see Figure 1—figure supplement 3), did not exist. In
this sense, the mechanical phenotyping of diagnostic changes of leukocytes directly in diluted whole
blood is the most transformative application area of MORE analysis. For example, there have been
proof-of-concept studies on the mechanical changes associated with activation of isolated neutro-
phils showing a stiffening, in line with the pronounced actin cortex that is a hallmark of neutrophil
activation (Worthen et al., 1989; Rosenbluth et al., 2008). MORE analysis of the in vitro neutrophil
activation in blood with the bacterial wall-derived tripeptide fMLP confirmed that neutrophils were
indeed less deformed and smaller within the first 15 min post fMLP treatment. Interestingly, the sub-
sequent time-course showed a reversal to more deformed and larger cells (Figure 3A,B; Figure 3—
figure supplement 1). These observations by themselves do not permit a conclusion about a change
in cell stiffness, since a smaller size also leads to less stress acting on the cells in the channel, and
less deformation (Mietke et al., 2015; Mokbel et al., 2017). Thus, we also calculated the apparent
Young’s modulus of the cells, which increased from E = 742 ± 12 Pa to E = 853 ± 20 Pa
(mean ±SEM. p=0.009, n = 5) during the first 15 min, and then subsequently reverted to values sta-
tistically indistinguishable but slightly lower than before stimulation (15–30 min: E = 717 ± 9 Pa,
p=0.347; 30–45 min: E = 719 ± 7 Pa, p=0.117; 45–60 min: E = 731 ± 11 Pa, p=0.465). Such mechani-
cal activation kinetics of neutrophils has not been reported before as the lower measurement rate of
previous techniques yielded only cumulative data over the time period investigated.
We also found a similar increase in size and greater deformation of the neutrophils at the later
time points in an experimental medicine trial, where healthy human volunteers inhaled lipopolysac-
charide (LPS; from E. coli) (Figure 3A,B; Figure 3—figure supplement 1). Also, infecting blood in
vitro with Staphylococcus aureus (S. aureus), a Gram-positive bacterium and one of the major patho-
gens responsible for life-threatening infections world-wide, resulted in larger and more deformed
neutrophils, measured between 30–60 min after blood stimulation (Figure 3A,B; Figure 3—figure
supplement 2).
Congruently, blood taken from patients with an acute lung injury (ALI) of most likely bacterial ori-
gin had larger and more deformed neutrophils compared to healthy controls (Figure 3C,E,H). The
same neutrophil response was found in blood samples from patients hospitalized with viral respira-
tory tract infections (RTI; Figure 3D,E,H). Also monocytes responded by a size increase in both RTI
and ALI patients and after in vitro stimulation with S. aureus, but showed a significantly increased
deformation only in viral RTI, while blood lymphocytes did not show any consistent response
(Figure 3F–H; Figure 3—figure supplements 2 and 3). The lymphocyte response changed when
analyzing blood of patients with acute Epstein-Barr-virus (EBV) infection, which is known to also stim-
ulate the lymphatic system, where both monocytes and lymphocytes showed an increase in cell size
and deformation, while neutrophils showed less of a response (Figure 3I–L, Figure 3—figure sup-
plement 3). These results suggest that MORE blood analysis might be sufficiently sensitive to distin-
guish bacterial from viral infections, and potentially other inflammatory diseases, by the differential
response of selective blood leukocyte populations. This possibility will be followed up in future spe-
cific trials. Importantly, MORE blood analysis is of special interest for blood tests in neonatology
with patients at high risk of infections but only minute amounts of blood available for diagnostics, or
to characterize neutrophils in neutropenic patients, as it merely requires longer data acquisition
periods.
Detection of morpho-rheological changes in malignant transformed
blood cells
Blood cancers, or leukemias, affecting both myeloid and lymphoid cell lineages, are a further large
area where MORE analysis could potentially contribute fundamental insight, aid diagnosis, and
improve therapy monitoring. While solid cancer cell mechanics has been a focus of cell mechanics
Toepfner et al. eLife 2018;7:e29213. DOI: https://doi.org/10.7554/eLife.29213 7 of 22
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research and extensively documented (Suresh, 2007; Kumar and Weaver, 2009; Guck and Chil-
vers, 2013), the mechanical properties of blood cancers are comparatively understudied.
The available research on mechanics of leukemic cells has been undertaken either on cell lines or
fully purified cells (Lichtman, 1973; Rosenbluth et al., 2006; Lam et al., 2008; Lichtman, 1970;
Figure 3. Identification of leukocyte activation and infection in vitro and in vivo. Relative change (mean ±SD) in (A) deformation and (B) size of
neutrophils in diluted whole blood after fMLP (n = 5 donors; see Figure 3—figure supplement 1) and S. aureus (n = 4 donors; see Figure 3—figure
supplement 2) stimulation in vitro measured 15–30 min and 30–60 min after stimulation, respectively, and LPS inhalation (n = 2 donors; see Figure 3—
figure supplement 1) in vivo measured 135 min after inhalation. Exemplary scatter plots of size vs. deformation of neutrophils in blood of a patient with
(C) ALI (magenta) and (D) RTI (green) compared to controls (black). Medians of size and deformation of (E, I) neutrophils, (F, J) monocytes, and (G, K)
lymphocytes in blood samples of patients with E, F, G, ALI (n = 4 patients; magenta) and RTI (n = 6 patients; green), and I, J, K, EBV infection (n = 5
patients; orange) relative to the norm (black, n = 21 donors as in Figure 1E with 68% and 95% confidence ellipses). (H, I) Mean and SD of these results,
*p<0.05. For typical scatter plots of size vs. deformation of all three cell types and all three disease conditions see Figure 3—figure supplement 3.
DOI: https://doi.org/10.7554/eLife.29213.017
The following source data and figure supplements are available for figure 3:
Source data 1. Source data for Figure 3.
DOI: https://doi.org/10.7554/eLife.29213.021
Figure supplement 1. Neutrophil response in blood during in vitro and in vivo stimulation.
DOI: https://doi.org/10.7554/eLife.29213.018
Figure supplement 2. In vitro stimulation of blood with Staphylococcus aureus.
DOI: https://doi.org/10.7554/eLife.29213.019
Figure supplement 3. Single cell distributions of neutrophils, lymphocytes, and monocytes from patients with ALI, RTI, and EBV compared to controls.
DOI: https://doi.org/10.7554/eLife.29213.020
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Dombret et al., 1995; Lautenschla¨ger et al., 2009; Ekpenyong et al., 2012; Rosenbluth et al.,
2008; Zheng et al., 2015) but so far not directly in blood. MORE analysis of the blood of patients
with acute myeloid (AML) and lymphatic leukemias (ALL) revealed the new presence of atypical cell
populations — the characteristic immature blasts not normally present in healthy donors
(Figure 4A–C). Cell populations gated for AML revealed less deformed cells but of about the same
size compared to healthy and fully differentiated myeloid cells (Figure 4D, Figure 4—figure supple-
ment 1), in line with previous results (Rosenbluth et al., 2006; Lichtman, 1970; Dombret et al.,
1995; Lautenschla¨ger et al., 2009; Ekpenyong et al., 2012). ALL blast cells were larger in size com-
pared to mature lymphocytes, but did not show any consistent trend in deformation (Figure 4D; Fig-
ure 4—figure supplement 1). Since cell size and deformation in the channel are interrelated
(Mietke et al., 2015; Otto et al., 2015; Mokbel et al., 2017), which can be seen by the isoelasticity
lines parameterizing the deformation-size space (Figure 4D), we also calculated the apparent
Young’s modulus of these cells (Figure 4—figure supplement 1). Together these results show that
mature lymphocytes, ALL blasts, mature myeloid cells, and AML blasts have increasing levels of stiff-
ness, consistent with the composite findings of previous reports (Lichtman, 1973; Rosenbluth et al.,
Figure 4. Detection and distinction of leukemia subtypes and monitoring of treatment effects. (A) Normal brightness vs. size scatter plot of a healthy
donor with the gates (shaded areas) used to identify lymphocytes (ly), basophils (ba), monocytes (mo), neutrophils (neu) and eosinophils (eo). (B)
Exemplary brightness vs. size scatter plot in AML; blast cells were found in (ba) and (mo) gates. (C) Exemplary brightness vs. size scatter plot in ALL;
blast cells were found in (ly), (ba), and (mo) gates. (D) Medians of deformation and size for the respective gates in blood samples of ALL (red circles,
n = 4 patients) and AML patients (purple triangles, n = 7 patients). Shaded areas in D (color as in A) represent 95% confidence ellipses of the respective
cell type norm (n = 21 donors, as in Figure 1E). Gray lines represent lines of equal elasticity calculated for purely elastic objects. Scatter plots of ALL
blast deformation and size at (E) one; (F) seven, and (G) twelve days post therapy start. Blue shaded areas in E-H represent 95% confidence ellipses of
the lymphocyte norm (n = 21 donors, as in Figure 1E). (H) Median deformation and size of ALL cells during 12 days of treatment (red dots, days as
numbers). Gray shaded areas surrounding data of days 1, 4, 8, and 12 represent the 68% (inner) and 95% (outer) confidence area of a single
measurement (according to lymphocyte confidence in Figure 1—figure supplement 6H).
DOI: https://doi.org/10.7554/eLife.29213.022
The following source data and figure supplement are available for figure 4:
Source data 1. Source data for Figure 4.
DOI: https://doi.org/10.7554/eLife.29213.024
Figure supplement 1. Comparison of ALL and AML blast cells with the norm.
DOI: https://doi.org/10.7554/eLife.29213.023
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2006; Lam et al., 2008; Lichtman, 1970; Dombret et al., 1995; Lautenschla¨ger et al., 2009;
Ekpenyong et al., 2012; Rosenbluth et al., 2008). This is quite different than the general trend in
solid tumors, where cancer cells are found to be more deformable than their healthy counterparts
(Suresh, 2007; Kumar and Weaver, 2009; Guck and Chilvers, 2013). Sensibly, the differential stiff-
ness of AML and ALL blasts, and its potential further increase with chemotherapy, has been impli-
cated in the occurrence of leukostasis (Lam et al., 2008; Rosenbluth et al., 2008; Lam et al., 2007).
MORE analysis might not only permit screening for novel therapeutic targets to soften cells
(Gossett et al., 2012; Di Carlo, 2012; Surcel et al., 2015), but also assessing the risk of leukostasis
directly in each patient.
Finally, by following the ALL blast population in a patient over 12 days of methylprednisolone
treatment we could monitor the return to the normal morpho-rheological fingerprint of blood
(Figure 4E–H). The evolution of this fingerprint likely comprises multiple contributions with blast
cells undergoing apoptosis over a time course of 2–7 days (Ito et al., 1996), which is associated with
an increase in stiffness (Lam et al., 2007). Blast cells are sequestered by the spleen and new, but
immature and likely stiffer, blast cells are being added to the circulation from the bone marrow.
There could also be ALL subclones with different morpho-rheological characteristics that respond
differently and at different times to treatment. And the final increase in deformation from day 9 to
12 coincides with the addition of cytostatic drugs (vincristine, daunorubicin) to the methylpredniso-
lone treatment. Dissecting this multifaceted response will be aided by adding simultaneous fluores-
cence identification of the cells in the future (Rosendahl, 2017). Of note, of the conventional
biomarkers and techniques that are used in the diagnosis of leukemia (see Supplementary file 2),
only morphological analysis of air-dried Romanowsky-stained blood (or bone marrow) smears is tra-
ditionally applied to monitor treatment success in ALL. The response to treatment is one of the most
powerful prognostic in vivo markers of leukemia survival. In pediatric ALL the number of blasts at
day eight after start of methylprednisolone treatment is predictive of the relapse rate (<1000 blasts/
ml of blood: relapse rate 20–30%; >1000 blasts/ml of blood: relapse rate 50–80%). MORE analysis
provides at least the same information as conventional morphological analysis, but in a shorter
amount of time and with smaller sample sizes required (for a comparison between MORE analysis
and conventional biomarkers, see Supplementary file 2). In summary, MORE blood analysis can be
used to monitor morpho-rheological effects of chemotherapy and the successful replacement of lym-
phoblasts with mature lymphocytes in a quantitative manner. This last finding also touches upon the
study of hematopoietic differentiation of cells in the bone marrow, which is an obvious further poten-
tial area of application of this approach.
Discussion
Morpho-rheological phenotyping allows individual blood cell mechanics to be studied in a range of
human diseases and takes cell mechanical phenotyping to an entirely new level. While established
techniques such as micropipette aspiration (Lichtman, 1973; Lichtman, 1970; Dombret et al.,
1995; Ravetto et al., 2014), indentation by cell pokers and atomic force microscopes
(Worthen et al., 1989; Rosenbluth et al., 2006; Lam et al., 2008), or optical trapping
(Lautenschla¨ger et al., 2009; Ekpenyong et al., 2012; Paul et al., 2013) have provided important
proof-of-concept insight over the last decades, the recent advent of microfluidic techniques
approaching the throughput of conventional flow cytometers (Gossett et al., 2012; Otto et al.,
2015; Zheng et al., 2015; Byun et al., 2013; Lange et al., 2015) has finally brought mechanical
phenotyping close to real-world applications (Guck and Chilvers, 2013; Tse et al., 2013). Amongst
the latter techniques, RT-DC stands out because it can continuously monitor an, in principle, unlim-
ited number of cells, which enables the direct sensitive assessment of the state of all major cell types
found in blood. A volume as small as 10 ml can be analyzed cell-by-cell, with only dilution in measure-
ment buffer to adjust cell density and prevent sedimentation, but no labeling, enrichment or separa-
tion, which could otherwise cause inadvertent activation of blood cells. The conventional blood
count is extended by information about characteristic, and diagnostic, morpho-rheological changes
of the major cell types. Cell mechanics and morphology are inherent and sensitive markers intimately
linked to functional changes associated with the cytoskeleton (Chimini and Chavrier, 2000;
Fletcher and Mullins, 2010; Kasza et al., 2007; Patel et al., 2012; Salbreux et al., 2012) and other
intracellular shape-determining and load-bearing entities (Rowat et al., 2006; Munder et al., 2016).
Toepfner et al. eLife 2018;7:e29213. DOI: https://doi.org/10.7554/eLife.29213 10 of 22
Tools and resources Biophysics and Structural Biology Human Biology and Medicine
Thus, label-free, disease-specific morpho-rheological blood signatures are a novel resource for gen-
erating hypotheses about the underlying molecular mechanisms. The availability of such parameters
in real-time, easily combined with conventional fluorescence detection (Rosendahl, 2017), are the
necessary prerequisite for future sorting of morpho-rheologically distinct subpopulations, which then
provides a novel opportunity for further molecular biological analysis. Of course, at present, MORE
phenotyping provides a sensitive, but not a very specific marker. For example, neutrophil softening
could be a signature of different underlying pathological changes. In the future, fuller exploration of
the large combinatorial space afforded by the multi-parametric response of the various blood cells,
exploiting many additional morpho-rheological parameters in conjunction with machine learning,
and inclusion of conventional fluorescence-based marker analysis (Rosendahl, 2017) will further
increase the specificity of this approach. Apart from now enabling realistic blood cell research ex
vivo close to physiological conditions, delivering for example previously unavailable information
about leukocyte activation kinetics, and after further in-depth studies of the phenomena reported
here, MORE phenotyping could have a tangible impact on diagnosis, prognosis, and monitoring of
treatment success of many hematological diseases as well as inflammatory, infectious, and metabolic
disorders. Beyond blood analysis, MORE phenotyping has the potential to become a standard
approach in flow cytometry with many applications in biology, biophysics, biotechnology, and
medicine.
Materials and methods
Real-time deformability cytometry
Real-time deformability cytometry (RT-DC) was carried out as described previously (Otto et al.,
2015). For RT-DC measurements, cells were suspended in a viscosity-adjusted measurement buffer
(MB) based on 1x phosphate buffered saline (PBS) containing methylcellulose. The viscosity was
adjusted to 15 mPa s at room (and measurement) temperature, determined using a falling ball vis-
cometer (Haake, Thermo Scientific). Cells in the MB were taken up into a 1 ml syringe, placed on a
syringe pump (neMESYS, Cetoni GmbH) and connected via tubing to the sample inlet of the micro-
fluidic chip with a square measurement channel cross section of 20  20 mm2. The microfluidic chip
was made from cured polydimethylsiloxane bonded to a thickness #2 cover glass. Another syringe
containing MB without cells was connected to the sheath flow inlet of the chip. Measurements were
carried out at a total flow rate of 0.12 ml/s with a sample flow rate of 0.03 ml/s and a sheath flow rate
of 0.09 ml/s unless stated otherwise. Different gating settings for cell dimensions could be employed
during the measurement (Figure 1—figure supplement 1). Images of the cells in the channel were
acquired in a region of interest of 250  80 pixels at a frame rate of 2000 fps. Real-time analysis of
the images was performed during the measurement and the parameters necessary for MORE analy-
sis were stored for all detected cells.
Data processing in MORE analysis
The raw data obtained from RT-DC measurements consisted of the following information of every
detected cell: a bright field image of the cell, the contour of the cell, its deformation value, and the
cell size as the cross-sectional area of the cell in the image (Figure 1—figure supplement 1). The
deformation was calculated from the convex hull contour of the cell — a processed contour, where
all points contributing to concave curvature were removed:
deformation¼ 1  2
ffiffiffiffiffiffiffi
pA
p
l
;
where A is the area enclosed by the convex hull contour and l is the length of the convex hull con-
tour. Therefore, deformation is the deviation from a perfectly circular cell image. It describes the
change of the cell’s shape by the hydrodynamic forces in the measurement channel but may also
contain pre-existing shape deviations from a sphere, for example for the biconcave, disk-like shapes
of healthy red blood cells or strongly activated and polarized neutrophils. Image brightness analysis
was carried out using the contour information and the image of the cell. The mean brightness of the
cell was determined from all pixel values within the cell’s contour (Figure 1D). With this information
the distinction of leukocyte subpopulations was possible in the space spanned by cell size and mean
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brightness (Figure 1D and Figure 1—figure supplement 2). It is worth noting that the absolute
value of the resulting brightness was influenced by several experimental conditions such as focus of
the image and the thickness of the microfluidic chip. However, this did not affect the quality of the
distinction of cells by their brightness. Special care had to be taken when comparing the brightness
of different purified leukocyte subpopulations of similar size (like neutrophils, eosinophils, and mono-
cytes). In order to achieve a situation similar to the diluted whole blood measurement, we used the
same microfluidic chip repeatedly after thorough flushing. All brightness values reported were nor-
malized to 100 by the background brightness of the channel. Apart from the initial brightness dis-
tinction, in a second step, the root mean square of pixel brightness values was calculated in an area
of 9  5 pixels (nine in the flow direction, five perpendicular to the flow direction) around the geo-
metrical center of the cell. This information was used to distinguish the relevant leukocyte subpopu-
lations from eventual erythrocyte doublets present (Figure 1D). To ensure best validity of the
deformation measure based on the area within the cell’s contour and the length of the contour, only
cells without prominent protrusions were considered for comparisons based on deformation. A reli-
able criterion to select those cells was found by comparing the area within the originally detected
cell contour and within the convex hull contour. For erythrocytes, the difference of these two areas
was limited to 15%. For leukocytes, a suitable limit was found at 5%. For the identification of
malaria-infected erythrocytes we used a semi-automated procedure designed to obtain only clearly
positive results and to avoid false negatives. The defining property of infected cells was the presence
of bright spots within the cells. In a first step, all pixel values outside the cell’s contour were set to 0.
In a twice-repeated procedure, the image of the erythrocyte was further reduced by setting all pixel
values of the contour pixels to 0 and finding the new contour. This measure was used to eliminate
possible bright spots due to fringes at the border of the cell. From this image, the brightness of
every pixel of the remaining cell was calculated by taking the mean of the pixel itself and its eight
nearest neighbors. The user was then able to set the minimal threshold for this brightness in order
to identify a cell as potentially infected. Since higher pixel values are frequently obtained at the rear
of the cell (in flow direction) only bright spots within 70% of the cell’s length counted from the front
of the cell were considered. As a last criterion, the calculated brightness was compared to the
brightness of the cell directly surrounding the bright spot in order to eliminate cases of generally
bright cells. For this a mean brightness value was formed from all pixels located within the two rect-
angular areas spanned from [k-3,l-1] to [k-2,l + 1] as well as [k + 2,l-1] to [k + 3,l + 1], where k is the
pixel position of the bright spot in the flow direction and l is the pixel position of the bright spot
orthogonal to the flow direction. Most of this analysis can be performed with ShapeOut, except for
the last aspect of considering details of internal brightness, for which a custom-written Python script
was used.
Blood measurements
All studies complied with the Declaration of Helsinki and involved written informed consent from all
participants or their legal guardians. Ethics for experiments with human blood were approved by the
ethics committee of the Technische Universita¨t Dresden (EK89032013, EK458102015), and for
human blood and LPS inhalation in healthy volunteers by the East of England, Cambridge Central
ethics committee (Study No. 06/Q0108/281 and ClinicalTrialReference NCT02551614). Study partici-
pants were enrolled according to good clinical practice and recruited at the University Medical Cen-
tre Carl Gustav Carus Dresden, Germany, the Biotechnology Center, Technische Universita¨t
Dresden, Germany, or Cambridge University Hospitals, Cambridge, UK. Human blood and serum
used to culture the malaria parasites was obtained from the Glasgow and West of Scotland Blood
Transfusion Service; the provision of the material was approved by the Scottish National Blood
Transfusion Service Committee For The Governance Of Blood And Tissue Samples For Non-Thera-
peutic Use. Venous blood was drawn from donors with a 20-gauge multifly needle into a sodium cit-
rate S-monovette (Sarstedt) by vacuum aspiration. In case of blood volumes above 9 ml, blood was
manually drawn via a 19-gauge multifly needle into a 40 ml syringe and transferred to 50 ml Falcon
polypropylene tubes (BD) containing 4 ml 3.8% sodium citrate (Martindale Pharmaceuticals). For RT-
DC measurements of blood, 50 ml of anti-coagulated blood were diluted in 950 ml MB and mixed
gently by manual rotation of the sample tube. This fixed dilution of 1:20 was the result of optimiza-
tion series to dilute as little possible, while still enabling the reliable detection of single cell events
for both erythrocytes and leukocytes at typical cell densities found in blood. Measurements were
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typically carried out within 2 hr past blood donation unless stated otherwise. Two different gating
settings were employed in the measurement software for erythrocyte and leukocyte acquisition,
respectively (Figure 1—figure supplement 1A). For erythrocytes, gates were essentially open allow-
ing cell dimensions in flow direction from 0 mm to 30 mm. The leukocyte gate was set to a size of 5–
16 mm in flow direction and >5 mm perpendicular to it. This setting allowed filtering out single eryth-
rocytes and almost all erythrocyte multiples. The leukocyte populations remained unaltered as con-
firmed in experiments with purified leukocytes at open gate settings. Using the leukocyte gate, the
majority of thrombocytes was also ignored as they possess typical diameters of 2–3 mm. A small frac-
tion of very large thrombocytes and microerythrocytes were still found within this gate as seen in
Figure 1C and D. Mechanical analysis of these events constitutes an interesting challenge in that
they can be detected and counted, but at present not tested for activation via their deformation
given their very small size compared to the channel size, which was chosen to accommodate all cells
found in blood. Measurements in the leukocyte gate were carried out over a fixed timespan of 15
min (to acquire typically 500 to 3000 leukocytes, depending on donor and disease state), followed
by a separate measurement in the erythrocyte gate for a few seconds until data of 5,000–10,000
cells were acquired. Measurements for establishing the normal MORE blood phenotype in healthy
human volunteers (Figure 1E), and all measurements directly compared to this norm, e. g., blood
samples derived from patients, were carried out at a temperature of 30˚C. The remaining measure-
ments — fMLP stimulation, LPS stimulation, purified leukocyte subpopulations, malaria infection,
and erythrocyte palmitoylation — were carried out at a temperature of 23˚C. The viscosity of the MB
was always adjusted to 15 mPa s at the different temperatures to keep the acting hydrodynamic
stress and, thus, the resulting deformation regimes the same. An MB with the viscosity of 25 mPa s
(to slow blood cell sedimentation in the tubing) was used in experiments for comparing the relative
cell count results of leukocyte subpopulation by MORE analysis and conventional blood count
(Figure 1F; Supplementary file 1). Here, the total flow rate was 0.06 ml/s (sample flow 0.015 ml/s,
sheath flow 0.045 ml/s) and images were acquired at 4000 fps.
Leukocyte purification and identification
Leukocyte subpopulations were purified by negative and/or positive magnetic-activated cell sorting
(MACS) following the instructions provided by the manufacturer. Reagents for cell isolation with
magnetic beads purchased from Miltenyi Biotec were MACSxpress Neutrophil Isolation Kit human
(130-104-434), Monocyte Isolation Kit human (130-091-153), Basophil Isolation Kit II human (130-092-
662), Pan T Cell Isolation Kit human (130-096-535) and CD3 MicroBeads (130-050-101), as well as
Pan B Cell Isolation Kit human (130-101-638) and CD19 MicroBeads (130-050-301). EasySep Human
Eosinophil Enrichment Kit (19256) was obtained from StemCell Technologies. The purity of the
derived cell isolates was controlled twice by staining with 7-Color-Immunophenotyping Kit (Miltenyi
Biotec, 5140627058), as well as additional single staining of each cell subset for fluorescence-acti-
vated cell sorting (FACS). Individual cell type staining antibodies from BioLegend were used for
granulocytes (target: CD66ACE, staining: PE, order no.: 342304, RRID:AB_2077337), eosinophils
(Siglec-8, APC, 347105, RRID:AB_2561401), B lymphocytes (CD19, FITC, 302205, RRID:AB_314235),
NK cells (CD56, PE, 318305, RRID:AB_604093), T helper cells (CD4, PE-Cy7, 300511, RRID:AB_
314079), T lymphocytes (CD3, APC, 300411, RRID:AB_314065), cytotoxic T cells (CD8, PacificBlue,
301026, RRID:AB_493111), monocytes (CD14, FITC, 325603, RRID:AB_830676), as well as eosino-
phils, basophils, mast cells, and mononuclear phagocytes (CD193, PE, 310705, RRID:AB_345395).
For RT-DC measurements, purified cells were pelleted by centrifugation (200 g, 5 min) and re-sus-
pended in MB at concentrations of about 5  106 cells/ml by repeated, gentle shaking.
In vitro malaria infection
Plasmodium falciparum (P. falciparum, HB3 clone, NCBI Taxonomy ID: 137071) cultures were grown
accordingly to standard protocols (Trager and Jensen, 1976). Two P. falciparum cultures were
grown independently for 3 weeks, treated with Plasmion (Lelie`vre et al., 2005) to enrich for the
schizont stages, and then allowed to reinvade fresh red blood cells in a shaking incubator for 3 hr.
The cultures were then treated with sorbitol (Lambros and Vanderberg, 1979), to remove all schiz-
onts that had not reached full maturity; only ring stage parasites survive sorbitol treatment. The
highly synchronized culture used for the RT-DC measurements therefore consisted of erythrocytes
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exposed to P. falciparum, into some of which parasites had invaded within a 3 hr window. Samples
were removed at 4, 12, 16, 20, 24, 36, 42 and 46 hr post invasion for the RT-DC measurements. At
the time of each measurement a thin blood smear was taken and stained with Giemsa’s stain to
assess the parasitemia and the stage of the parasites (Figure 2—figure supplement 2A). A control
sample of the same blood without the parasites underwent the identical treatment as the P. falcipa-
rum exposed samples. For RT-DC measurements, at each time point, 10 ml of the blood culture were
diluted in 990 ml of the MB to a final concentration of 2.5  105 cells/ml. The total flow rate through
the channel was 0.04 ml/s for all malaria infection experiments (sample flow rate 0.01 ml/s, sheath
flow rate 0.03 ml/s). For experiments on growth and invasion depending on erythrocyte palmitoyla-
tion status, blood, treated as described in the palmitoylation section below, was shipped from Ger-
many to Scotland in PBS buffer containing 15 mM glucose, 5 mM sodium pyruvate, 5 mM Coenzyme
A, 5 mM MgCl2, 5 mM KCl, 130 mM NaCl. Parasites were synchronized by collecting P. falciparum
mature stages (trophozoites and schizonts) from P. falciparum clone HB3 using MACS columns
(Ribaut et al., 2008). The trophozoite and schizont enriched cultures were mixed with erythrocytes
to achieve a starting parasitemia of 0.5–1.0%. Each erythrocyte type was set up in a separate culture
flask at 3 ml volume and 5% hematocrit. The parasites were incubated in a shaking incubator at 37˚C
under standard culture conditions of gas and medium. Parasitemia was monitored on day 2 (post
invasion) and day 4 (second round of invasion). For all experimental conditions, a minimum of 500
RBCs were counted. Experiments were repeated on three different days with erythrocytes of 3 dif-
ferent donors yielding the same results.
Palmitoylation of erythrocytes
Red blood cells were pelleted by blood centrifugation (800 g, 5 min), plasma was removed, and the
RBCs were pretreated with one volume of 1% fatty acid-free bovine serum albumin (BSA) in PBS-glu-
cose (10 mM phosphate, 140 mM NaCl, 5 mM KCl, 0.5 mM EDTA, 5 mM glucose, pH 7.4) at 37˚C
for 15 min, in order to lower the endogenous content of free fatty acids in their membrane pools,
and washed three times with PBS-glucose. Cells were re-suspended in 3 volumes of incubation
buffer, containing 40 mM imidazole, 90 mM NaCl, 5 mM KCl, 5 mM MgCl2, 15 mM D-glucose, 0.5
mM EGTA, 30 mM sucrose, 5 mM sodium pyruvate, 5 mM Coenzyme A, 50 mg PMSF/ml and 200 U
penicillin/streptomycin (320 mOsm, pH 7.6). For inhibition of palmitoylation, 100 mM final concentra-
tion of 2-bromopalmitate (2 BP) was used. 100 mM palmitic acid (PA) was added as a control. The
RBCs were incubated in a humidified incubator with 5% CO2 for 24 hr at 37˚C. Prior to measure-
ment, RBCs were pelleted, re-suspended in 1% BSA, incubated for 15 min at 37˚C and washed two
times with PBS-glucose. Glucose, sucrose, 2-bromopalmitate, palmitic acid, fatty acid free BSA,
Coenzyme A, and PMSF were purchased from Sigma-Aldrich; Penicillin/streptomycin and sodium
pyruvate from Gibco. RT-DC measurements were carried out at a room temperature of 23˚C and
with a total flow rate of 0.032 ml/s (sample flow 0.008 ml/s, sheath flow 0.024 ml/s) after adding 10 ml
of the RBC suspension to 990 ml of MB. Experiments were carried out on two different days with
erythrocytes of 4 different donors.
fMLP-induced neutrophil activation
For in vitro fMLP stimulation, blood was stimulated with 100 nM N-Formylmethionyl-leucyl-phenylal-
anine (fMLP; Sigma-Aldrich, 47729, 10 mg-F). Separate samples were analyzed in time intervals of 0–
15 min, 15–30 min, 30–45 min, and 45–60 min after activation. During incubation all samples were
stored in 2 ml Eppendorf tubes at 37˚C at 450 rpm in a ThermoMicer C (Eppendorf). All experiments
were performed within 2 hr maximum after blood drawing. Experiments were repeated with blood
samples of 5 different donors on five different days. Due to experimental feasibility PBS controls of
these donors were measured before fMLP stimulation and after the 60 min fMLP sample. Addition-
ally, three control samples of different donors were treated similarly adding 10 ml 1 x PBS instead of
fMLP and were analyzed in time intervals of 0–15 min, 15–30 min, 30–45 min, and 45–60 min after
bleeding to exclude kinetic effects due to blood alteration with storage.
In vitro Staphylococcus aureus infection
Blood stimulation was performed with Staphylococcus aureus Newmann strain (S. aureus; ATCC
25904; NCBI Taxonomy ID: 426430). For reproducible repetitive testing with competent bacterial
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strains cryo-aliquots of S. aureus were prepared as follows. Bacterial cells were pre-cultured to the
log phase for synchronization of growth in BHI broth (Bacto Brain Heart Infusion, Becton Dickinson)
at 37˚C and transferred to a second culture. Aiming at a high bacterial virulence factor expression,
the cells were grown to an early stationary phase in a 96-well-plate (100 ml, OD600nm 0.1837, Infinite
200 reader, TECAN), pelleted by centrifugation (2671 g for 5 min at 4˚C), washed two times in PBS
and re-suspended in cell-freezing media (Iscove Basal Medium, Biochrom) with 40% endotoxin-free
FBS (FBS Superior, Biochrom) at a final concentration of 2.54109 CFU/ml. Aliquots were immediately
frozen at –80˚C and only thawed once for a single experiment. Blood stimulation and measurement
were carried out at 30˚C temperature for 15 min with one multiplicity of infection (MOI) in 1:20 RT-
DC measurement buffer. MOI (0.9–1.09) was controlled retrospectively by granulocyte count and 5%
sheep blood agar culture (Columbia agar, bioMe´rieux) at 37˚C and bacterial colony counting on the
following day. PBS blood controls were conducted before and after S. aureus blood stimulation. The
experiment was repeated with blood of 4 different donors on four different days. All experiments
were performed within 2 hr after blood drawing.
LPS inhalation
E. coli lipopolysaccharide (LPS) 50 mg (GSK) was administered to healthy, never-smoker volunteers
via a specialized dosimeter (MB3 Markos Mefar) 90 min prior to injection of autologous 99mTechne-
tium-Hexamethylpropleneamine-oxime labeled neutrophils. Temperature, forced expiratory volume
in 1 s, forced ventilator capacity and triplicate blood pressures were recorded prior to, and at 30
min post LPS administration. RT-DC measurements were obtained at baseline, 90, 135, 210, 330,
and 450 min post LPS.
Respiratory tract infections (RTI) and acute lung injury (ALI)
Patient inclusion criteria for RTI: Patients with clinical signs of lower RTI, a core temperature >38.5˚C
and the need for supplemental oxygen were recruited on the day of hospitalization. Only patients
without treatment prior to hospitalization were included. None of the included patients received
antibiotic treatment for reconstitution. Patient inclusion criteria for ALI: Patients diagnosed with ALI
according to the criteria of the North American European Consensus Conference (NAECC)
(Bernard et al., 1994) and without underlying diseases prior to ALI were included. All blood samples
were analyzed within 30 min of venipuncture. Size and deformation of blood leukocytes was charac-
terized for all blood cells in which the area within the original cell contour differed less than 5% from
the area within the convex hull contour.
Acute myeloid/lymphatic leukemias
Samples from patients diagnosed with ALL or AML based on cytogenetic, molecular-genetic and
morphological criteria according to WHO classification from 2008 (Vardiman et al., 2009) were
assessed by MORE blood analysis on the day of diagnosis. In order to evaluate mechanical proper-
ties of AML and ALL blast cells in diluted whole blood, several brightness and size gates had to be
combined as shown in Figure 4A–C. The AML gate spanned the regions normally used for basophils
and monocytes. The ALL gate spanned the regions used for lymphocytes, basophils and monocytes.
In all AML cases, blasts made up >80% of all leukocytes, and up to 99% of events in the AML gate.
In all ALL cases, blasts made up >60% of leukocytes, and up to 85% of events in the ALL gate. The
blast cell fraction was obtained from the standard differential blood count, by comparing the num-
ber of blast cells with the number of normal cells that would also populate the respective blasts gate
in MORE analysis.
Isoelasticity lines and young’s moduli
RT-DC data of cell size and deformation can be converted into apparent Young’s moduli using theo-
retical models (Mietke et al., 2015) and numerical simulations (Mokbel et al., 2017). To ensure a
correct conversion, effects of shear thinning of the MC medium and a deformation offset due to pix-
elation were taken into account as described in Herold, 2017. The calculation of apparent Young’s
moduli for AML and ALL blasts and isoelasticity lines are based on the assumption that cells can be
approximated as purely elastic, homogeneous isotropic spheres. This assumption is equivalent to
using the Hertz model to extract an apparent Young’s modulus of cells in atomic force microscopy-
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enabled nano-indentation experiments. The conversion of deformation and size into Young’s modu-
lus for every cell measured is included in the analysis software ShapeOut.
Statistics
Throughout, the number of cells in a single measurement is denoted as N, while the number of inde-
pendently repeated experiments — typically the number of donor or patient samples measured, as
stated — is denoted as n. For comparison of different donors or treatment conditions the median of
deformation and cell size of a specific cell population was used. In order to evaluate effects of a dis-
ease we calculated a 2D confidence ellipse at 68.3% (or one sigma) as well as 95.5% (or two sigma)
for the control group/norm norm of healthy human blood donors in the space of cell size and defor-
mation. The confidence ellipse was calculated from the covariance matrix of the data and the calcu-
lation was carried out with OriginPro 2015 (Originlab). Statistically significant differences between
two sets of experiments were checked to the significance level of p<0.05 by comparing the groups
of individual median values of an experiment using a Kruskal-Wallis one-way ANOVA as imple-
mented in OriginPro 2015 (Originlab). In erythrocyte MORE analysis in malaria infection and palmi-
toylation, statistically significant differences were checked using linear mixed models in combination
with a likelihood ratio test to obtain significance levels for the comparison of the complete popula-
tions (Herbig et al., 2017). This analysis can be performed in the software ShapeOut. One, two, or
three asterisks were awarded for significance levels p<0.05, p<0.01 and p<0.001, respectively. In
manual counts of malaria infection in RBCs, statistical analyses were performed using a c2 test with
Bonferroni correction (adjusted statistical significance for p<0.0125) to compare the numbers of
infected and non-infected erythrocytes between erythrocyte samples, except where number of para-
site infected cells was zero, in which case Fisher‘s exact test was used. The standard deviation for
the parasitemia was calculated assuming a binomial random variable as SD ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiN  p 1  pð Þp , where
N is the number of cells counted and p is the fraction of infected cells.
Data availability
The raw data of all measurements are available from the Dryad Digital Repository (Toepfner et al.,
2017). The TDMS files can be read, processed, and analyzed using ShapeOut, a custom written,
open source software.
Code availability
RT-DC measurement software is commercially available. The analysis software ShapeOut is available
as an open source application on GitHub (https://github.com/ZELLMECHANIK-DRESDEN/Shape-
Out/releases; Mu¨ller, 2017). A copy is archived at https://github.com/elifesciences-publications/
ShapeOut.
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are not detected (up to 40% of all cells). However, this affects all leukocytes similarly so that the rela-
tive counts are not changed.
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. Supplementary file 2. Table comparing conventional biomarkers of leukemia with MORE analysis.
(1) Morphological analysis of air-dried Romanowsky (Wright, Wright-Giemsa, or May-Gru¨nwald-
Giemsa)-stained blood or bone marrow smears. The morphological features identified by micro-
scopic examination may suggest either lymphoid or myeloid differentiation of leukemic cells, but
with the exception of the identification of Auer rods in myeloblasts none of these features is lineage-
specific. Sub-clones can be identified by differences in size and morphological features (e. g. cyto-
plasmatic vacuoles). (2) Cytochemical staining improves the accuracy and reproducibility of lineage
assessment and therefore is required for traditional sub-classification of acute myeloid leukemia
(AML) according to the French-American-British (FAB) and WHO criteria. Sudan Black and stains for
myeloperoxidase (MPO) to identify myeloblasts and esterase stains like alpha-naphthyl-butyrate to
identify monoblasts have remained useful in this regard. Staining must be performed without undue
delay as MPO is unstable and becomes undetectable after a week of storage. (3) Immunophenotypic
classification is based on identification of cell surface epitopes or cytoplasmatic proteins by fluores-
cent dye-labeled antibodies. Flow cytometry (fluorescence-activated cell sorting, FACS) is nowadays
widely used as a particularly powerful method because multiparameter analysis offers the advantage
of segregating leukemic cells from non-neoplastic cells. Thus, rapid analysis allows to establish the
lineage of the leukemia (e.g. myeloid versus lymphoid), its stage of differentiation (e. g. T- versus
B-ALL) and facilitates minimal residual disease (MRD) monitoring using a leukemia-specific pattern of
markers not expressed in that combination on regular blood or bone marrow cells. Notably, some
precursor B-cell ALL might be negative for CD45 (leukocyte common antigen) or patients with T-ALL
lack TdT or CD34 expression. Although ALL can be classified according to the stage of maturation,
the optimal immunologic sub-classification remains a matter of debate. Many ALLs also aberrantly
express myeloid-linage associated antigens (mostly CD13, CD33). Therefore the antibody screening
panel for acute leukemias must be designed to include at least one very sensitive and one relatively
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specific marker for each hematopoietic and lymphoid lineage. (4) Molecular (genetic) classification
using traditional methods will detect specific cytogenetic and/or molecular abnormalities in 60–80%
of ALL and 50–60% of AML cases. The recent advent of whole genome analysis has allowed virtually
all acute leukemias to be classified according to specific genetic abnormalities. Markers can be sepa-
rated into leukemia-specific (e.g. BCR-ABL1; t(15;18)) or leukemic-clone specific (e.g. Ig-heavy chain
gene rearrangements, T-cell receptor gene rearrangements). Both are valuable for classification, as
prognostic indicators with a defined treatment applied, and are nowadays routinely used for moni-
toring of MRD by exploiting the high sensitivity of PCR-based amplification of specific gene sequen-
ces. The technique is time-consuming and expensive, and usually performed only in reference
laboratories. (5) MORE analysis. When compared to these established conventional methods, the
advantages of morpho-rheological (MORE) phenotyping are characterized by a very short time for
analysis and the minimum amount of blood required. The technique has comparable power with
regard to the identification of leukemic cells and the identification of leukemic sub-clones. Its appli-
cability to classify the leukemic lineage (for example by significant differences in size, deformation,
and Young’s modulus; see Figure 4—figure supplement 1) and to detect small numbers of leuke-
mic cells can theoretically be expected and has been shown in single cases already, but still has to
be tested and proven in a formal comparison, which is beyond the scope of the present study.
Potentially, the rheological features of blast cells might represent additional prognostic biomarkers
for leukemic cells (stiffness might correlate to drug sensitivity or refractoriness, or identify a leukemic
subclone), which will be the subject of future studies. Morpho-rheological phenotyping, thus, com-
pares very well to established biomarkers for following ALL treatment success.
DOI: https://doi.org/10.7554/eLife.29213.026
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.29213.027
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